Paper19084037
Polymersome delivery of siRNA and antisense oligonucleotides.
Kim Y and 11 others. J Control Release, 2009. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Polymersome delivery of siRNA and antisense oligonucleotides. Papers, record 19084037. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19084037
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanocapsules | Major topic |
| Oligonucleotides, Antisense | Major topic |
| RNA, Small Interfering | Major topic |
| Animals | |
| Biocompatible Materials | |
| Cell Line | |
| Cell Nucleus | |
| Delayed-Action Preparations | |
| Dystrophin | |
| Gene Expression Regulation | |
| Lamins | |
| Mice | |
| Mice, Inbred mdx | |
| Muscle Fibers, Skeletal |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 EB007049 | NIBIB NIH HHS | United States | R01EB007049 | PubMed and NIH | NIH RePORTER |
| R01 HL062352 | NHLBI NIH HHS | United States | R01HL062352 | PubMed and NIH | NIH RePORTER |
| R21 AR056128 | NIAMS NIH HHS | United States | R21AR056128 | PubMed and NIH | NIH RePORTER |
| S10 RR022575 | NCRR NIH HHS | United States | S10RR022575 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16096010 | In vivo application of RNA interference: from functional genomics to therapeutics. | Adv Genet | 2005 | https://conductscience.org/library/papers/16096010 | PubMed |
| 2 | 17904724 | Protein precipitation and denaturation by dimethyl sulfoxide. | Biophys Chem | 2007 | https://conductscience.org/library/papers/17904724 | PubMed |
| 3 | 15608067 | Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15608067 | PubMed |
| 4 | 15709955 | Rnai as an experimental and therapeutic tool to study and regulate physiological and disease processes. | Annu Rev Physiol | 2005 | https://conductscience.org/library/papers/15709955 | PubMed |
| 5 | 12847521 | Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. | Nat Med | 2003 | https://conductscience.org/library/papers/12847521 | PubMed |
| 6 | 15294170 | Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides. | Mol Ther | 2004 | https://conductscience.org/library/papers/15294170 | PubMed |
| 7 | 16159254 | Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. | J Am Chem Soc | 2005 | https://conductscience.org/library/papers/16159254 | PubMed |
| 8 | 11120883 | Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11120883 | PubMed |
| 9 | 12169723 | Polymer vesicles. | Science | 2002 | https://conductscience.org/library/papers/12169723 | PubMed |
| 10 | 11792820 | Identification of essential genes in cultured mammalian cells using small interfering RNAs. | J Cell Sci | 2001 | https://conductscience.org/library/papers/11792820 | PubMed |
| 11 | 15522893 | Adhesion-contractile balance in myocyte differentiation. | J Cell Sci | 2004 | https://conductscience.org/library/papers/15522893 | PubMed |
| 12 | 8475120 | Dystrophin protects the sarcolemma from stresses developed during muscle contraction. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8475120 | PubMed |
| 13 | 11255161 | Preparation, stability, and in vitro performance of vesicles made with diblock copolymers. | Biotechnol Bioeng | 2001 | https://conductscience.org/library/papers/11255161 | PubMed |
| 14 | 16610765 | Modification of pre-mRNA processing: application to dystrophin expression. | Curr Opin Mol Ther | 2006 | https://conductscience.org/library/papers/16610765 | PubMed |
| 15 | 12206800 | Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. | Neuromuscul Disord | 2002 | https://conductscience.org/library/papers/12206800 | PubMed |
| 16 | 18368052 | Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. | Nature | 2008 | https://conductscience.org/library/papers/18368052 | PubMed |
| 17 | 18160687 | Local dystrophin restoration with antisense oligonucleotide PRO051. | N Engl J Med | 2007 | https://conductscience.org/library/papers/18160687 | PubMed |
| 18 | 16488666 | Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers. | Mol Ther | 2006 | https://conductscience.org/library/papers/16488666 | PubMed |
| 19 | 14991021 | Oxidation-responsive polymeric vesicles. | Nat Mater | 2004 | https://conductscience.org/library/papers/14991021 | PubMed |
| 20 | 8546385 | Improved cationic lipid formulations for in vivo gene therapy. | Ann N Y Acad Sci | 1995 | https://conductscience.org/library/papers/8546385 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935498 | Gene therapy as an upcoming technique in the treatment of cancer: A cellular solution to a cellular problem. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42935498 | PubMed |
| 40720026 | Use of Glucose/Fructose to Enhance the Exon Skipping Efficacy. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40720026 | PubMed |
| 40166479 | Synthetic-polymer-assisted antisense oligonucleotide delivery: targeted approaches for precision disease treatment. | Beilstein J Nanotechnol | 2025 | https://conductscience.org/library/papers/40166479 | PubMed |
| 39420230 | Nanomedicine Therapies for Pediatric Diseases. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2024 | https://conductscience.org/library/papers/39420230 | PubMed |
| 38907698 | Polyglycerol-Shelled Reduction-Sensitive Polymersome for DM1 Delivery to HER-2-Positive Breast Cancer. | Biomacromolecules | 2024 | https://conductscience.org/library/papers/38907698 | PubMed |
| 38344270 | USE OF ARTIFICIAL CELLS AS DRUG CARRIERS. | Mater Chem Front | 2021 | https://conductscience.org/library/papers/38344270 | PubMed |
| 36401030 | Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36401030 | PubMed |
| 36277396 | Polymeric nanoparticles-Promising carriers for cancer therapy. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36277396 | PubMed |
| 36110562 | Nanocarriers for delivery of siRNA as gene silencing mediator. | EXCLI J | 2022 | https://conductscience.org/library/papers/36110562 | PubMed |
| 35575255 | Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications. | Angew Chem Int Ed Engl | 2022 | https://conductscience.org/library/papers/35575255 | PubMed |
| 35223804 | Research Progress and Prospects for Polymeric Nanovesicles in Anticancer Drug Delivery. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/35223804 | PubMed |
| 34011152 | Fate of Antibody-Targeted Ultrasmall Gold Nanoparticles in Cancer Cells after Receptor-Mediated Uptake. | ACS Nano | 2021 | https://conductscience.org/library/papers/34011152 | PubMed |
| 33669654 | Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/33669654 | PubMed |
| 31409996 | Stimulus-responsive vesicular polymer nano-integrators for drug and gene delivery. | Int J Nanomedicine | 2019 | https://conductscience.org/library/papers/31409996 | PubMed |
| 28398005 | Nanotherapy for Duchenne muscular dystrophy. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2018 | https://conductscience.org/library/papers/28398005 | PubMed |
| 26442597 | Expansile crosslinked polymersomes for pH sensitive delivery of doxorubicin. | Biomater Sci | 2016 | https://conductscience.org/library/papers/26442597 | PubMed |
| 26258054 | Synthesis and self-assembly of biodegradable polyethylene glycol-poly (lactic acid) diblock copolymers as polymersomes for preparation of sustained release system of doxorubicin. | Int J Pharm Investig | 2015 | https://conductscience.org/library/papers/26258054 | PubMed |
| 25204288 | Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. | J Control Release | 2014 | https://conductscience.org/library/papers/25204288 | PubMed |
| 24506782 | Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for Duchenne muscular dystrophy. | Nucleic Acid Ther | 2014 | https://conductscience.org/library/papers/24506782 | PubMed |
| 24448480 | Label-free mass spectrometry exploits dozens of detected peptides to quantify lamins in wildtype and knockdown cells. | Nucleus | 2013 | https://conductscience.org/library/papers/24448480 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DMD | 1756 | PubTator's text mining | https://conductscience.org/library/genes/1756 | NCBI Gene |
| LMNA | 4000 | PubTator's text mining | https://conductscience.org/library/genes/4000 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19084037
GET https://conductscience.org/api/papers/v1/19084037/references?page=2